LENZ Therapeutics, Inc.

Ownership Transactions Reported by 29 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+12.7K	0.7%	$22.78	+$289K
Sells	2	-1.9M	99.3%	$35.28	-$66.9M
Net	0	-1.88M	-98.7%		-$66.6M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Versant Venture Capital VI, L.P.	10%+ Owner	$85.3M	-$66.6M	-43.8%	Sep 30, 2025
EcoR1 Capital, LLC	10%+ Owner	$34.8M			Jan 6, 2023
Samsara BioCapital, L.P.	10%+ Owner	$34.7M			Apr 11, 2022
James W. Mccollum	Director	$29.1M	+$239K	+0.83%	Nov 7, 2025
Versant Venture Capital VII, L.P.	10%+ Owner	$6.52M			Mar 21, 2024
Phil Gutry	Chief Business Officer	$1.22M			Apr 11, 2022
Katherine V. Stultz	Chief Operating Officer	$881K			Jun 24, 2021
Marc Odrich	Chief Medical Officer	$406K			Jan 9, 2025
Daniel R. Chevallard	Chief Financial Officer	$123K	+$50K	+68.9%	Nov 7, 2025
Evert B. Schimmelpennink	President, CEO and Secretary, Director	$51.2K			Mar 7, 2025
Shawn Olsson	Chief Commercial Officer	$9.85K			Nov 17, 2025
Matthew Porteus	Director				Jul 19, 2023
Alethia Young	Chief Financial Officer				Feb 21, 2023
Kristen Hege	Director				Jul 19, 2023
Joanne L. Viney	Director				Jul 19, 2023
Smital Shah	Director				Jul 19, 2023
Abraham Bassan	Director				Jul 19, 2023
Carlo Rizzuto	Director				Jul 19, 2023
Perry A. Karsen	Director				Jul 19, 2023
Joseph Jimenez	Director				Jul 19, 2023
Jerel Davis	Director				Jul 19, 2023
Joshua Lehrer-Graiwer	PRESIDENT AND CEO, Director				Feb 21, 2023
Jeffrey P. George	Director				Jun 11, 2025
Shelley B. Thunen	Director				Jun 11, 2025
Frederic Guerard	Director				Jun 11, 2025
Alpha Wave Ventures GP, Ltd	10%+ Owner				Mar 21, 2024
Kimberlee C. Drapkin	Director				Jun 11, 2025
Zachary Scheiner	Director				Jun 11, 2025
Ra Capital Management, L.P.	Director, 10%+ Owner				Jun 11, 2025

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.